In vitro Anti-hepatitis C Virus (HCV) Activities and Resistance Profile of Debio 025, A Non-immunosuppressive Cyclophilin Binding Molecule
Lotte Coelmont(Rega Institute for Medical Research), Johan Neyts(Rega Institute for Medical Research), Suzanne J. F. Kaptein(Rega Institute for Medical Research), Inge Vliegen(Rega Institute for Medical Research), Jan Paeshuyse(Rega Institute for Medical Research), Philippe Gallay(Scripps Research Institute), Grégoire Vuagniaux(Debiopharm (Switzerland)), Michael Bobardt(Scripps Research Institute)
Cited by 1
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Animal models for COVID-19
|Nature|2020|877
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338